European Commission approves Ronapreve to treat Covid-19

Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus

Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients

A final decision regarding the approval of Ronapreve is expected from the European Commission shortly

Covaxin well tolerated with no safety concerns: Lancet

Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.

Sanofi to invest up to US $ 60 million in Gyroscope

A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).

Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021

Transforming Healthcare Through AI

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.

KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals

The combined entity will have 12 hospitals with 3,666 beds

Oasis Fertility forays into Karnataka plans 10 more centres

It plans to double its network to 50 centres across India in the next three years